Skip to main content
TipRanks
Go Ultimate75% OFF

ACADIA Pharmaceuticals (ACAD) Q3 2022 Earnings Report

2,464 Followers

ACAD Q3 2022 EPS Results

Actual EPS
-$0.17
Consensus EPS
-$0.19
Beat/Miss
Beat by +$0.02
One Year Ago EPS
-$0.09

ACAD Q3 2022 Revenue Results

Actual Revenue
$130.71M
Expected Revenue
$138.76M
Beat/Miss
Missed by -$8.05M
YoY Revenue Growth
-0.68%

Earnings Announcement Details

Quarter
Q3 2022
Date
11/02/2022
Time
After Close
Conference Call
Wednesday, November 2, 2022
ACAD Upcoming Earnings

ACADIA Pharmaceuticals's next earnings date is estimated for March 1, 2027, based on past reporting schedules.

Q3 2022 Earnings Call Audio

ACAD Q3 2022 Earnings Call
0:00 / 0:00

Q3 2022 Earnings Slide Deck

Q3 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

ACAD Earnings History

ACAD earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 01, 20272026 (Q4)0.27-1.6――
Nov 04, 20262026 (Q3)0.200.310.42-26.19% (-0.11)
Aug 04, 20262026 (Q2)0.070.180.1612.50% (+0.02)
May 06, 20262026 (Q1)0.050.020.11-81.82% (-0.09)
Feb 25, 20262025 (Q4)0.141.600.8686.05% (+0.74)
Nov 05, 20252025 (Q3)0.170.420.2110.00% (+0.22)
Aug 06, 20252025 (Q2)0.140.160.2-20.00% (-0.04)
May 07, 20252025 (Q1)0.090.110.110.00% (+0.01)
Feb 26, 20252024 (Q4)0.220.860.28207.14% (+0.58)
Nov 06, 20242024 (Q3)0.140.20-0.4150.00% (+0.60)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed